𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Repetitive transcranial magnetic stimulation for the treatment of negative symptoms in residual schizophrenia: rationale and design of a sham-controlled, randomized multicenter study

✍ Scribed by Joachim Cordes; P. Falkai; B. Guse; A. Hasan; T. Schneider-Axmann; M. Arends; G. Winterer; W. Wölwer; E. Ben Sliman; M. Ramacher; C. Schmidt-Kraepelin; C. Ohmann; B. Langguth; M. Landgrebe; P. Eichhammer; E. Frank; J. Burger; G. Hajak; M. Rietschel; T. Wobrock

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
228 KB
Volume
259
Category
Article
ISSN
1433-8491

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, sham-controlled, proof of
A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia
✍ Felipe Fregni; Rafaela Gimenes; Angela C. Valle; Merari J. L. Ferreira; Renata R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective Recent evidence suggests that fibromyalgia is a disorder characterized by dysfunctional brain activity. Because transcranial direct current stimulation (tDCS) can modulate brain activity noninvasively and can decrease pain in patients with refractory central pain, we hypot

The impact of left prefrontal repetitive
The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study
✍ Endre Pal; Ferenc Nagy; Zsuzsanna Aschermann; Eva Balazs; Norbert Kovacs 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract Based on several open‐label and case studies, repetitive transcranial magnetic stimulation (rTMS) seems to have an antidepressive effect on patients with Parkinson's disease (PD). However, this hypothesis requires further confirmation. We conducted a randomized, double‐blind placebo‐con

Efficacy of selegiline add on therapy to
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study
✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of